Amos Chungwon Lee, PhD profile page

Dr. Amos Chungwon Lee is the CEO and co-founder of Meteor Biotech, Co. Ltd., a company dedicated to advancing spatial omics solutions. Alongside his leadership at Meteor Biotech, he is also a co-founder and serves on the Scientific Advisory Board for Bhomegen, Co. Ltd. Lee received his BS in bioengineering from the University of California, Berkeley. He then earned his PhD in bioengineering from Seoul National University, where his doctoral thesis pioneered spatially-resolved laser-activated cell sorting for genomics and transcriptomics in biological specimens. Prior to his current executive roles, he served as a postdoctoral scholar and a research assistant professor at the Bio-MAX Institute at Seoul National University. His extensive research expertise encompasses translational medicine, spatial omics, DNA nanotechnology, and BioMEMS. As a leading expert in his field, Lee has directed high-impact research initiatives as a principal investigator.